NEW YORK (GenomeWeb News) – Officials from the Fred Hutchinson Cancer Research Center have said that the more than $40 million in American Recover and Reinvestment Act funding the center recently won could enable it to bring back some of the staffers it laid off this past spring, though not permanently.

Back in April, the Seattle-based Hutchinson center announced it had eliminated 83 positions, comprising 3 percent of its total workforce. The center cited declines in its philanthropic giving and investment income, both key sources of its discretionary funds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.